Development of Dynamic Combinatorial Libraries for Cruzipain Inhibition

Cruzipain 抑制动态组合文库的开发

基本信息

  • 批准号:
    7462303
  • 负责人:
  • 金额:
    $ 5.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-01 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This Fogarty International Research Collaboration Award (FIRCA) application has been designed to expand and enhance the parent grant P01 CA78039 (Project PI Wipf, Peter), and to expand and increase the research capacity of the foreign scientist (Dr. Mahler, S. Graciela) and the foreign institution (University of the Republic, Montevideo Uruguay). Specific aims are: 1. Design and synthesis of new scaffolds to generate dynamic combinatorial libraries: (a) using pyrazolotriazinones and aldehydes as building blocks; (b) using new heterocyclic systems with aldehydes as building blocks. 2. Identify compounds with biological significance for Chagas disease: (a) test the libraries using the enzyme cruzipain in order to identify inhibitors by changes in the library distributionor by dynamic deconvolution; (b) compounds showing affinity to cruzipain will be submitted for in vitro cruzipain inhibition; (c) compounds having good inhibition activities will be submitted to a Trypanosoma cruzi growth inhibition assay in vitro, in order to evaluate the trypanocidal activity. The biological assay will be carried out by Prof. Cazzulo at Universidad Nacional de San Martin, San Martin, Provincia de Buenos Aires, Argentina. This proposal and the parent grant thus share common goals related to the development of dynamic combinatorial methodologies to achieve these objectives. Chagas disease, caused by Tripanosoma cruzi, is a major public health problem in Latin America, where it constitutes one of the largest parasitic disease burdens. The treatment of this condition has been controversial, but there is a growing consensus that elimination of T. cruzi could be a prerequisite to arrest the evolution of the disease. Currently available chemotherapy, based on a nifurtimox and benznidazol, is unsatisfactory because of their limited efficacy in the prevalent chronic stage of the disease and their toxic side effects. New approaches to specific chemotherapy are being advanced; biochemical routes like cruzipain-mediated proteolysis have been chemically validated and selective in vitro and in vivo anti-T. cruzi activities of inhibitors of this pathway have been demonstrated. Successful completion of the major aims of this program will provide a new lead in cruzipain inhibition abd open up the possibility to find a new drug-like molecule useful in Chagas disease as well as new exchange reactions useful for the generation of dynamic combinatorial libraries Chagas disease, caused by Tripanosoma cruzi, is a major public health problem in Latin America, where it constitutes one of the largest parasitic disease burdens. The treatment of this condition has been controversial, but there is a growing consensus that elimination of T. cruzi could be a prerequisite to arrest the evolution of the disease.
描述(由申请人提供):Fogarty国际研究合作奖(FIRCA)的申请旨在扩大和加强P01 CA78039(皮特·皮威夫项目)的父母资助,并扩大和提高外国科学家(马勒博士,S.Graciela博士)和外国机构(共和国大学,蒙得维的亚乌拉圭)的研究能力。具体目标是:1.设计和合成生成动态组合文库的新支架:(A)使用吡唑三氮酮和醛作为构建块;(B)使用以醛为构建块的新杂环体系。2.鉴定对恰加斯病具有生物学意义的化合物:(A)使用CRUZIPIN酶对文库进行测试,以便通过改变文库分布或通过动态去卷积来确定抑制剂;(B)对CRUZIPIN具有亲和力的化合物将被提交体外CRUZIPIN抑制;(C)具有良好抑制活性的化合物将被提交体外克氏锥虫生长抑制试验,以评价其杀锥虫活性。生物化验将由卡祖洛教授在阿根廷布宜诺斯艾利斯省圣马丁国立大学进行。因此,这项提案和母方赠款在开发动态组合方法以实现这些目标方面有着共同的目标。查加斯病是由克氏三盘虫引起的,是拉丁美洲的一个主要公共卫生问题,构成了最大的寄生虫病负担之一。这种疾病的治疗一直存在争议,但越来越多的人达成共识,认为根除克鲁兹旋毛虫可能是阻止疾病演变的先决条件。目前可用的以硝呋莫司和苯硝唑为基础的化疗并不令人满意,因为它们在疾病的慢性期疗效有限,而且有毒副作用。针对特定化疗的新方法正在发展中;化学途径,如克鲁兹痛介导的蛋白质分解,已经在体外和体内得到了化学验证和选择性的抗T。这一途径的抑制剂的CRUZI活性已被证明。这一计划的主要目标的成功完成将为抑制查加斯病提供新的先导,并为发现可用于查加斯病的新的类药物分子以及用于生成动态组合文库的新的交换反应打开可能性。查加斯病是拉丁美洲的一个主要公共卫生问题,构成了最大的寄生虫病负担之一。这种疾病的治疗一直存在争议,但越来越多的人达成共识,认为根除克鲁兹旋毛虫可能是阻止疾病演变的先决条件。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter Wipf其他文献

Peter Wipf的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter Wipf', 18)}}的其他基金

Innovative Medicinal Chemistry
创新药物化学
  • 批准号:
    8010806
  • 财政年份:
    2010
  • 资助金额:
    $ 5.83万
  • 项目类别:
Novel Heterocyclic Libraries
新型杂环文库
  • 批准号:
    7557567
  • 财政年份:
    2008
  • 资助金额:
    $ 5.83万
  • 项目类别:
Novel Heterocyclic Libraries
新型杂环文库
  • 批准号:
    7684262
  • 财政年份:
    2008
  • 资助金额:
    $ 5.83万
  • 项目类别:
Novel Heterocyclic Libraries
新型杂环文库
  • 批准号:
    7902201
  • 财政年份:
    2008
  • 资助金额:
    $ 5.83万
  • 项目类别:
Novel Heterocyclic Libraries
新型杂环文库
  • 批准号:
    7925160
  • 财政年份:
    2008
  • 资助金额:
    $ 5.83万
  • 项目类别:
Development of Dynamic Combinatorial Libraries for Cruzipain Inhibition
Cruzipain 抑制动态组合文库的开发
  • 批准号:
    7635885
  • 财政年份:
    2007
  • 资助金额:
    $ 5.83万
  • 项目类别:
Development of Dynamic Combinatorial Libraries for Cruzipain Inhibition
Cruzipain 抑制动态组合文库的开发
  • 批准号:
    7290864
  • 财政年份:
    2007
  • 资助金额:
    $ 5.83万
  • 项目类别:
Innovative Medicinal Chemistry Core
创新药物化学核心
  • 批准号:
    8940569
  • 财政年份:
    2005
  • 资助金额:
    $ 5.83万
  • 项目类别:
COMBINATORIAL CHEMISTRY AND DIVERSITY-ORIENTED SYNTHESIS
组合化学和面向多样性的合成
  • 批准号:
    6923499
  • 财政年份:
    2005
  • 资助金额:
    $ 5.83万
  • 项目类别:
COMBINATORIAL SYNTHESIS OF ANTICANCER LIBRARIES
抗癌文库的组合合成
  • 批准号:
    6928830
  • 财政年份:
    2005
  • 资助金额:
    $ 5.83万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了